Written Question·Department of Health and Social Care·UIN 106960

Sodium Valproate: Health Services

Tabled: 20 January 2026

Answered: 29 January 2026

Question

Bob Blackman

To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate.

Answer

Dr Zubir Ahmed

There are established systems within the National Health Service to ensure that cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate. In practice, this involves establishing arrangements for assessin...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 106960) →